1960
DOI: 10.1135/cccc19601929
|View full text |Cite
|
Sign up to set email alerts
|

Metabolism of folic acid. VI. Preparation of intermediary antimetabolites of folic acid

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

1961
1961
2002
2002

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 0 publications
0
6
0
Order By: Relevance
“…In summary, seven novel 2,4-diamino-5-deaza- 6,7,8,9-tetrahydropyrido[3,4-g]pteridine derivatives with a varied benzyl and a benzoyl substitution at the N7 position (3)(4)(5)(6)(7)(8)(9) were designed and synthesized as classical and nonclassical, conformationally restricted, linear, tricyclic 5-deaza antifolates to investigate the effect of the conformational restriction, of C6-C9 (τ 1 ) and C9-N10 (τ 2 ) bonds via an ethyl bridge from the N10 to the C7 position of 5-deaza MTX, with respect to the inhibitory potency against different pathogenic DHFR and antitumor activity. Biological studies indicated that this conformational modification was detrimental to DHFR inhibitory activity as well as to antitumor activity compared to MTX or 5-deaza MTX.…”
Section: Biological Evaluation and Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In summary, seven novel 2,4-diamino-5-deaza- 6,7,8,9-tetrahydropyrido[3,4-g]pteridine derivatives with a varied benzyl and a benzoyl substitution at the N7 position (3)(4)(5)(6)(7)(8)(9) were designed and synthesized as classical and nonclassical, conformationally restricted, linear, tricyclic 5-deaza antifolates to investigate the effect of the conformational restriction, of C6-C9 (τ 1 ) and C9-N10 (τ 2 ) bonds via an ethyl bridge from the N10 to the C7 position of 5-deaza MTX, with respect to the inhibitory potency against different pathogenic DHFR and antitumor activity. Biological studies indicated that this conformational modification was detrimental to DHFR inhibitory activity as well as to antitumor activity compared to MTX or 5-deaza MTX.…”
Section: Biological Evaluation and Discussionmentioning
confidence: 99%
“…Because of the frequent occurrence of tumor resistance and ineffectiveness against many solid tumors, extensive structural modifications of MTX have been reported to improve its antitumor spectrum of activity and to circumvent tumor resistance. [4][5][6][7] One area of structural modification that may afford increased biological activity is conformational restriction of flexible parts of a lead molecule.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Sepharose 4B was obtained from Pharmacia, cyanogen bromide from Schuchardt, w-alkylenediamines from Lachema, deoxyuridine 5'-monophosphate from Koch-Light. Tetrahydrofolate was prepared from folic acid by catalytic hydrogenation in acetic acid with subsequent precipitation of the product with ether (Slavik et al, 1960). Tetrahydromethotrexate was prepared by a similar procedure from methotrexate Lederle (Slavik et al, 1960).…”
Section: Methodsmentioning
confidence: 99%
“…Tetrahydrofolate was prepared from folic acid by catalytic hydrogenation in acetic acid with subsequent precipitation of the product with ether (Slavik et al, 1960). Tetrahydromethotrexate was prepared by a similar procedure from methotrexate Lederle (Slavik et al, 1960). The material contained about 70% of the mixture of two diastereomers of tetrahydromethotrexate, 20% dihydromethotrexate, and a small amount of p-methylaminobenzoyl glutamate (as shown by gradient elution on DEAE-cellulose column).…”
Section: Methodsmentioning
confidence: 99%